FDA.reportPublic FDA data

12.5 ML lutetium Lu 177 vipivotide tetraxetan 27 MCI/ML Injection [Pluvicto]

RxCUI
2597060
RxNorm name
12.5 ML lutetium Lu 177 vipivotide tetraxetan 27 MCI/ML Injection [Pluvicto]
Display name
12.5 ML lutetium Lu 177 vipivotide tetraxetan 27 MCI/ML Injection [Pluvicto]
Full name
12.5 ML lutetium Lu 177 vipivotide tetraxetan 27 MCI/ML Injection [Pluvicto]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PLUVICTOLUTETIUM LU 177 VIPIVOTIDE TETRAXETANNovartis Pharmaceuticals Corporation14908037-2892-4d98-a053-253ce35afb1a2026-08-12Warnings, Adverse reactionsExact identifier
rxcui: 2597060

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
14908037-2892-4d98-a053-253ce35afb1aPLUVICTO 1000 MBq/mL (27 MCI/ML) Injection [PSN] · 12.5 ML lutetium Lu 177 vipivotide tetraxetan 27 MCI/ML Injection [Pluvicto] [SBD] · Pluvicto 200 mCi per 12.5 ML Injection [SY] · Pluvicto 7.4 GBq per 12.5 ML Injection [SY]43These highlights do not include all the information needed to use PLUVICTO safely and effectively. See full prescribing information for PLUVICTO. PLUVICTO ® (lutetium Lu 177 vipivotide tetraxetan) injection, for intravenous use Initial U.S. Approval: 202220260407